To examine potential synergistic effects of synthetic PPAR and RXR ligands on these lines, we treated human breast cancer cells with the PPARα agonist clofibrate, the PPARγ selective ligand ciglitazone, and the RXR selective agonist AGN194204. This evidence concerns the gene PPARA and breast carcinoma.